ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Alison M. Schram

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-6070-2413; OpenAlex author ID A5088495181. Sources: ClinicalTrials.gov.

Their work

Papers: 1
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 1

NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. Co-author DOI 10.1093/jnci/djaf361 ↗

Trials 1

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy) Principal investigator NCT02912949 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.24
- Paper NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. DOI 10.1093/jnci/djaf361 ↗
Olca Baştürk · 1 shared paper, 2026 · strength 0.24
- Paper NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. DOI 10.1093/jnci/djaf361 ↗
Richard Kinh Gian Do · 1 shared paper, 2026 · strength 0.24
- Paper NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in pancreatic cancer. DOI 10.1093/jnci/djaf361 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.